Smallpox cost-effectiveness of therapy: Difference between revisions
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) |
||
| Line 7: | Line 7: | ||
==Cost-Effectiveness of Therapy== | ==Cost-Effectiveness of Therapy== | ||
Today, since there is no available [[antiviral]] treatment for [[smallpox]], the [[vaccine]] is the only cost for the treatment. | Today, since there is no available [[antiviral]] treatment for [[smallpox]], the [[vaccine]] is the only cost for the treatment.<ref name="MooreSeward2006">{{cite journal|last1=Moore|first1=Zack S|last2=Seward|first2=Jane F|last3=Lane|first3=J Michael|title=Smallpox|journal=The Lancet|volume=367|issue=9508|year=2006|pages=425–435|issn=01406736|doi=10.1016/S0140-6736(06)68143-9}}</ref> | ||
In the past the development and distribution of the bifurcated [[needle]] represented one of the costs. This [[needle]] improved the ease and cost of [[vaccination]] About 1,000 needles cost only $5. The [[needle]] could be boiled and reused hundreds of times. Also, since these [[needle]] required a smaller amount of [[vaccine]] the vials of [[vaccine]] could now vaccinate 4 times as many people. This was an important achievement since there were certain countries that could not afford any sort of [[vaccination]] above a very minimal cost. | In the past the development and distribution of the bifurcated [[needle]] represented one of the costs. This [[needle]] improved the ease and cost of [[vaccination]] About 1,000 needles cost only $5. The [[needle]] could be boiled and reused hundreds of times. Also, since these [[needle]] required a smaller amount of [[vaccine]] the vials of [[vaccine]] could now vaccinate 4 times as many people. This was an important achievement since there were certain countries that could not afford any sort of [[vaccination]] above a very minimal cost. | ||
Revision as of 02:21, 11 July 2014
|
Smallpox Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Smallpox cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Smallpox cost-effectiveness of therapy |
|
Risk calculators and risk factors for Smallpox cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
The efforts made in the eradication smallpox were cost-effective since the disease was successfully eradicated in 1980.
Cost-Effectiveness of Therapy
Today, since there is no available antiviral treatment for smallpox, the vaccine is the only cost for the treatment.[1]
In the past the development and distribution of the bifurcated needle represented one of the costs. This needle improved the ease and cost of vaccination About 1,000 needles cost only $5. The needle could be boiled and reused hundreds of times. Also, since these needle required a smaller amount of vaccine the vials of vaccine could now vaccinate 4 times as many people. This was an important achievement since there were certain countries that could not afford any sort of vaccination above a very minimal cost.
References
- ↑ Moore, Zack S; Seward, Jane F; Lane, J Michael (2006). "Smallpox". The Lancet. 367 (9508): 425–435. doi:10.1016/S0140-6736(06)68143-9. ISSN 0140-6736.